Latest news
News section
Stay up to date with the latest news, insights, and developments shaping our work and our journey.
AstriVax receives the “Best Pitch Award” at Immunity for Health from Flanders Vaccine, sponsored by the Biotech Innovation Procurement Platform (BIPP)
Read moreAstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors
Read moreAstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
Read moreAstriVax enters clinical phase with its novel vaccine platform technology
Read moreAstriVax Rounds Out ExecutiveTeam with Chief Business Officer(CBO) Dr. Gregory Fanning
Read moreAstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccineastrivax-awarded-3-million-grant-to-advance
Read moreAstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
Read moreDr. Christian Brander and Dr. Mala Maini Join World-class Scientific Advisory Board of AstriVax
Read moreAstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
Read moreRead the testimonial of AstriVax CEO Hanne Callewaert in the BVA | Belgian Venture Capital & Private Equity Association
Read moreAstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development
Read moreHappy readings on this article in Vaccine Insights, based on an interview with two of the AstriVax co-founders Kai Dallmeier and Hanne Callewaert, describing the advantages of the Plasmid Launching Live Attenuated Virus (PLLAV) technology that is being further developed at AstriVax. Published by Charlotte Barker, editor in Vaccine Insights.
Read moreNice article on AstriVax in ‘De Tijd’ with our CEO Hanne Callewaert and PMV. Thank you Bart De Taeye and Filip Goossens from PMV to highlight the importance of a strong team as necessary ingredient for a successful start-up.
Read moreAstriVax receives the European Lifestar Award for ‘Seed-Stage Finance Raise of the Year 2022’ by LSX – partnering for Life Science eXecutives
Read moreDr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax
Read moreAstriVax: thermostable, plug-and-play vaccines using plasmids – Biocentury
Read moreLeuvense vaccinstart-up tankt record van 30 miljoen euro
Read moreKU Leuven spin-off AstriVax raises €30 million to build vaccine platform
Read more